Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Information From United States Firms and Processors That Export to the European Community, 11446-11448 [2014-04348]
Download as PDF
<![CDATA[
11446
Federal Register / Vol. 79, No. 40 / Friday, February 28, 2014 / Notices
Total number
of respondents
Instrument
Annual
number of
respondents
Number of
responses per
respondent
Average
burden hour
per response
Estimated
annual burden
hours
Head Start parent survey for plus study ..............................
Head Start parent supplemental survey for plus study .......
Head Start teacher child report for plus study ....................
Head Start teacher survey for plus study ............................
Head Start program director survey for plus study .............
Head Start center director survey for plus study .................
Early care and education administrators plus survey .........
Early care and education providers plus survey .................
1,350
1,350
150
150
50
100
600
900
450
450
50
50
17
33
200
300
2
2
20
2
2
2
2
2
0.25
0.08
0.17
0.50
0.25
0.25
0.50
0.50
225
72
170
50
8
17
200
300
Total ..............................................................................
........................
........................
........................
........................
4,514
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade, SW., Washington, DC
20447, Attn: OPRE Reports Clearance
Officer. Email address:
OPREinfocollection@acf.hhs.gov. All
requests should be identified by the title
of the information collection.
The Department specifically requests
comments on (a) whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–1620]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Information From
United States Firms and Processors
That Export to the European
Community
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
Karl Koerper,
OPRE Reports Clearance Officer.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by March 31,
2014.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0320. Also
include the FDA docket number found
in brackets in the heading of this
document.
[FR Doc. 2014–04400 Filed 2–27–14; 8:45 am]
FOR FURTHER INFORMATION CONTACT:
tkelley on DSK3SPTVN1PROD with NOTICES
BILLING CODE 4184–22–P
VerDate Mar<15>2010
17:47 Feb 27, 2014
Jkt 232001
SUMMARY:
FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 1350 Piccard
Dr., PI50–400B, Rockville, MD 20850,
PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Information From United States Firms
and Processors That Export to the
European Community (OMB Control
Number 0910–0320)—Extension
The European Community (EC) is a
group of 27 European countries that
have agreed to harmonize their
commodity requirements to facilitate
commerce among member States. EC
legislation for intra-EC trade has been
extended to trade with non-EC
countries, including the United States.
For certain food products, including
those listed in this document, EC
legislation requires assurances from the
responsible authority of the country of
origin that the processor of the food is
in compliance with applicable
regulatory requirements. The European
Commission, the executive branch of
the EC, requires countries trading with
any of the EC member countries to
provide lists of firms and processors
approved to export certain animalderived commodities to the EC. As
stated in the notice published in the
Federal Register of April 4, 1996 (61 FR
15077), we established a list of U.S.
firms and processors that intended to
export shell eggs, dairy products, and
game meat and game meat products to
the EC.
Although our 1996 Federal Register
notice did not include on the list firms
and processors exporting raw, bulk
collagen, and gelatin intended for
human consumption, EC directives
require that shipments of raw, bulk
collagen, and gelatin products be
accompanied by certification stating
that the product, derived from ruminant
bones, bovine hides, and pigskins, has
been produced in compliance with EC
Council Directive 2003/863/EC. The
directive contains the requirements for
sourcing, manufacture, transport, and
storage of raw materials and
manufacture of finished products.
Chapter III, Article 23, of the directive
requires lists identifying non-EC firms
and processors that meet EC
requirements and have the appropriate
animal and public health certificates.
E:\FR\FM\28FEN1.SGM
28FEN1
11447
Federal Register / Vol. 79, No. 40 / Friday, February 28, 2014 / Notices
Therefore, we revised this information
collection in order to facilitate exports
of raw, bulk collagen, and gelatin
originating from the United States into
the EC. We announced OMB approval of
the revised information collection in the
Federal Register of May 10, 2011 (76 FR
27061).
We request the following information
from each firm or processor seeking to
be included on the lists for shell eggs,
dairy products, game meat, game meat
products, and animal casings:
• Business name and address;
• Name and telephone number of
person designated as business contact;
• Lists of products presently being
shipped to the EC and those intended to
be shipped in the next 6 months;
• Name and address of manufacturing
plants for each product; and
• Names and affiliations of any
Federal, State, or local governmental
agencies that inspect the plant,
government-assigned plant identifier
such as plant number, and last date of
inspection.
We use the information to maintain
lists of firms and processors that have
demonstrated current compliance with
U.S. requirements. We provide the lists
to the EC quarterly. Inclusion on the list
is voluntary. EC member countries refer
to the lists at ports of entry to verify that
products offered for importation to the
EC from the United States are from firms
and processors that meet U.S. regulatory
requirements. Products processed by
firms and processors not on the lists are
subject to detention and possible refusal
at the port.
We request the following information
from each firm or processor seeking to
be included on the lists for raw, bulk
collagen, and gelatin:
• Business name and address;
• Name, telephone number, and
email address of contact person;
• List of products presently shipped
to the EC and those intended to be
shipped within the next 2 years;
• Name and address of the
manufacturing and processing plant for
each product;
• Names and affiliations of any
Federal, State, and local governmental
agencies that inspect the plant,
government assigned plant identifier,
such as plant number and last date of
inspection; and
• A copy of the most recent (within
1 year of the date of application)
inspection report issued by a State, local
or Federal public health regulatory
agency and a copy of a recent laboratory
analysis as required by the EC of the
finished product including: Total
aerobic bacteria, coliforms (30 °C),
coliforms (44.5 °C), anaerobic sulphitereducing bacteria (no gas production),
Clostridium perfringens,
Staphylococcus aureus, Salmonella,
Arsenic, Lead, Cadmium, Mercury,
Chromium, Copper, Zinc, Moisture (105
°C), Ash (550 °C), SO2, and H2O2.
We use the information to maintain a
list of approved firms and processors for
raw, bulk collagen, and gelatin. We
make the list available on our Web site.
We include on the list only firms and
processors that are not the subject of an
unresolved regulatory enforcement
action. If a listed firm or processor
subsequently becomes the subject of a
regulatory enforcement action or an
unresolved warning letter, we will view
such a circumstance as evidence that
the firm or processor is no longer in
compliance with applicable U.S. laws
and regulations. Should this occur, we
will take steps to remove that firm or
processor from the list and send a
revised list to the EC authorities, usually
within 48 to 72 hours after the relevant
regulatory enforcement action. If a firm
or processor has been delisted as a
result of a regulatory enforcement action
or unresolved warning letter, the firm or
processor will have to reapply for
inclusion on the list once the regulatory
action has been resolved.
We update the list of firms and
processors eligible to export raw, bulk
collagen, and gelatin to the EC quarterly.
Firms and processors placed on the
approved exporters list are subject to
audit by FDA and EC officials. Complete
requests for inclusion must be
submitted to us every 12 months to
remain on the list. Inclusion on the list
is voluntary. However, raw, bulk
collagen, and gelatin products from
firms or processors not on the approved
exporters list for these products will not
receive an export certificate, and these
products may be detained at EC ports of
entry.
Description of Respondents: The
respondents to this collection of
information include U.S. producers of
shell eggs, dairy products, game meat,
game meat products, animal casings,
gelatin, and collagen.
In the Federal Register of December
26, 2013 (78 FR 78364) FDA published
a 60-day notice requesting public
comment on the proposed collection of
information. No comments were
received.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Products
Number of
responses
per
respondent
Total annual
responses
Average
burden per
response
Total hours
Shell Eggs ............................................................................
Dairy .....................................................................................
Game Meat and Game Meat Products ...............................
Animal Casings ....................................................................
Gelatin ..................................................................................
Collagen ...............................................................................
10
120
5
5
3
3
1
1
1
1
1
1
10
120
5
5
3
3
0.25
0.25
0.25
0.25
0.25
0.25
3
30
1
1
1
1
Total ..............................................................................
........................
........................
........................
........................
37
tkelley on DSK3SPTVN1PROD with NOTICES
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
We base our estimates of the number
of respondents and total annual
responses on the submissions that we
have received in the past 3 years for
each product type. We have retained our
previous estimates of total annual
VerDate Mar<15>2010
18:37 Feb 27, 2014
Jkt 232001
responses because the number of
submissions are few and have remained
relatively stable. To calculate the
estimate for the hours per response
values, we assumed that the information
requested is readily available to the
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
submitter. We expect that the submitter
will need to gather information from
appropriate persons in the submitter’s
company and to prepare this
information for submission. We believe
that this effort should take no longer
E:\FR\FM\28FEN1.SGM
28FEN1
11448
Federal Register / Vol. 79, No. 40 / Friday, February 28, 2014 / Notices
than 15 minutes (0.25 hour) per
response. We estimate that we will
receive 1 submission from 10 shell egg
producers annually, for a total of 10
annual responses. Each submission is
estimated to take 0.25 hour per response
for a total of 2.5 hours, rounded to 3. We
estimate that we will receive 1
submission from 120 dairy product
producers annually, for a total of 120
annual responses. Each submission is
estimated to take 0.25 hour per response
for a total of 30 hours. We estimate that
we will receive one submission from
five game meat and game meat product
producers annually, for a total of five
annual responses. Each submission is
estimated to take 0.25 hour per response
for a total of 1.25 hours, rounded to 1
hour. We estimate that we will receive
one submission from five animal casings
producers annually, for a total of five
annual responses. Each submission is
estimated to take 0.25 hour per response
for a total of 1.25 hours, rounded to 1
hour. We estimate that we will receive
one submission from three gelatin
producers annually, for a total of three
annual responses. Each submission is
estimated to take 0.25 hour per response
for a total of 0.75 hour, rounded to 1
hour. We estimate that we will receive
one submission from three collagen
producers annually, for a total of three
annual responses. Each submission is
estimated to take 0.25 hour per response
for a total of 0.75 hour, rounded to 1
hour. Therefore, the proposed annual
burden for this information collection is
37 hours.
Dated: February 24, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–04348 Filed 2–27–14; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–D–0180]
tkelley on DSK3SPTVN1PROD with NOTICES
Draft Guidance for Industry on
Attachment to Guidance on Antiviral
Product Development—Conducting
and Submitting Virology Studies to the
Agency: Guidance for Submitting
Human Immunodeficiency Virus-1
Resistance Data; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of a draft guidance for
SUMMARY:
VerDate Mar<15>2010
17:47 Feb 27, 2014
Jkt 232001
industry entitled ‘‘Attachment to
Guidance on Antiviral Product
Development—Conducting and
Submitting Virology Studies to the
Agency: Guidance for Submitting HIV–
1 Resistance Data.’’ The purpose of this
guidance is to assist sponsors in
submitting human immunodeficiency
virus (HIV) clinical virology data that
are important for supporting clinical
trials of products in development for the
treatment of HIV. HIV resistance data
submitted in appropriately formatted
datasets are critical components in the
review of investigational antiviral
products for the treatment of HIV. The
information in this guidance will
facilitate the development of anti-HIV
products. This draft guidance revises
the guidance for industry entitled
‘‘Attachment to Guidance on Antiviral
Product Development—Conducting and
Submitting Virology Studies to the
Agency: Guidance for Submitting HIV
Resistance Data’’ issued on June 5, 2006.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
either electronic or written comments
on the draft guidance by April 29, 2014.
ADDRESSES: Submit written requests for
single copies of the draft guidance to the
Division of Drug Information, Center for
Drug Evaluation and Research, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, rm. 2201,
Silver Spring, MD 20993–0002. Send
one self-addressed adhesive label to
assist that office in processing your
requests. See the SUPPLEMENTARY
INFORMATION section for electronic
access to the draft guidance document.
Submit electronic comments on the
draft guidance to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Lisa
K. Naeger, Center for Drug Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg., 22, rm. 6366, Silver Spring,
MD 20993–0002, 301–796–0771.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
a draft guidance for industry entitled
‘‘Attachment to Guidance on Antiviral
Product Development—Conducting and
Submitting Virology Studies to the
Agency: Guidance for Submitting HIV–
1 Resistance Data.’’ The purpose of this
PO 00000
Frm 00059
Fmt 4703
Sfmt 9990
guidance is to assist sponsors in
submitting HIV clinical virology data
that are important for supporting
clinical trials of products in
development for the treatment of HIV.
This guidance revises and replaces the
guidance on submitting HIV resistance
data published in June 2006. The
revised guidance provides the format,
recommended definitions,
standardization of column headings and
variables, and recommended data for
submission of HIV resistance datasets.
This draft guidance is being issued
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
The draft guidance, when finalized, will
represent the Agency’s current thinking
on submitting HIV clinical virology
data. It does not create or confer any
rights for or on any person and does not
operate to bind FDA or the public. An
alternative approach may be used if
such approach satisfies the
requirements of the applicable statutes
and regulations.
II. The Paperwork Reduction Act of
1995
This guidance refers to previously
approved collections of information that
are subject to review by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995
(44 U.S.C. 3501–3520). The collections
of information in 21 CFR part 312 have
been approved under OMB control
number 0910–0014.
III. Comments
Interested persons may submit either
electronic comments regarding this
document to https://www.regulations.gov
or written comments to the Division of
Dockets Management (see ADDRESSES). It
is only necessary to send one set of
comments. Identify comments with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
IV. Electronic Access
Persons with access to the Internet
may obtain the document at either
https://www.fda.gov/Drugs/Guidance
ComplianceRegulatoryInformation/
Guidances/default.htm or https://
www.regulations.gov.
Dated: February 24, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–04425 Filed 2–27–14; 8:45 am]
BILLING CODE 4160–01–P
E:\FR\FM\28FEN1.SGM
28FEN1
]]>Agencies
[Federal Register Volume 79, Number 40 (Friday, February 28, 2014)]
[Notices]
[Pages 11446-11448]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-04348]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2013-N-1620]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Information From
United States Firms and Processors That Export to the European
Community
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by March
31, 2014.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-0320.
Also include the FDA docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville,
MD 20850, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Information From United States Firms and Processors That Export to the
European Community (OMB Control Number 0910-0320)--Extension
The European Community (EC) is a group of 27 European countries
that have agreed to harmonize their commodity requirements to
facilitate commerce among member States. EC legislation for intra-EC
trade has been extended to trade with non-EC countries, including the
United States. For certain food products, including those listed in
this document, EC legislation requires assurances from the responsible
authority of the country of origin that the processor of the food is in
compliance with applicable regulatory requirements. The European
Commission, the executive branch of the EC, requires countries trading
with any of the EC member countries to provide lists of firms and
processors approved to export certain animal-derived commodities to the
EC. As stated in the notice published in the Federal Register of April
4, 1996 (61 FR 15077), we established a list of U.S. firms and
processors that intended to export shell eggs, dairy products, and game
meat and game meat products to the EC.
Although our 1996 Federal Register notice did not include on the
list firms and processors exporting raw, bulk collagen, and gelatin
intended for human consumption, EC directives require that shipments of
raw, bulk collagen, and gelatin products be accompanied by
certification stating that the product, derived from ruminant bones,
bovine hides, and pigskins, has been produced in compliance with EC
Council Directive 2003/863/EC. The directive contains the requirements
for sourcing, manufacture, transport, and storage of raw materials and
manufacture of finished products. Chapter III, Article 23, of the
directive requires lists identifying non-EC firms and processors that
meet EC requirements and have the appropriate animal and public health
certificates.
[[Page 11447]]
Therefore, we revised this information collection in order to
facilitate exports of raw, bulk collagen, and gelatin originating from
the United States into the EC. We announced OMB approval of the revised
information collection in the Federal Register of May 10, 2011 (76 FR
27061).
We request the following information from each firm or processor
seeking to be included on the lists for shell eggs, dairy products,
game meat, game meat products, and animal casings:
Business name and address;
Name and telephone number of person designated as business
contact;
Lists of products presently being shipped to the EC and
those intended to be shipped in the next 6 months;
Name and address of manufacturing plants for each product;
and
Names and affiliations of any Federal, State, or local
governmental agencies that inspect the plant, government-assigned plant
identifier such as plant number, and last date of inspection.
We use the information to maintain lists of firms and processors
that have demonstrated current compliance with U.S. requirements. We
provide the lists to the EC quarterly. Inclusion on the list is
voluntary. EC member countries refer to the lists at ports of entry to
verify that products offered for importation to the EC from the United
States are from firms and processors that meet U.S. regulatory
requirements. Products processed by firms and processors not on the
lists are subject to detention and possible refusal at the port.
We request the following information from each firm or processor
seeking to be included on the lists for raw, bulk collagen, and
gelatin:
Business name and address;
Name, telephone number, and email address of contact
person;
List of products presently shipped to the EC and those
intended to be shipped within the next 2 years;
Name and address of the manufacturing and processing plant
for each product;
Names and affiliations of any Federal, State, and local
governmental agencies that inspect the plant, government assigned plant
identifier, such as plant number and last date of inspection; and
A copy of the most recent (within 1 year of the date of
application) inspection report issued by a State, local or Federal
public health regulatory agency and a copy of a recent laboratory
analysis as required by the EC of the finished product including: Total
aerobic bacteria, coliforms (30 [deg]C), coliforms (44.5 [deg]C),
anaerobic sulphite-reducing bacteria (no gas production), Clostridium
perfringens, Staphylococcus aureus, Salmonella, Arsenic, Lead, Cadmium,
Mercury, Chromium, Copper, Zinc, Moisture (105 [deg]C), Ash (550
[deg]C), SO2, and H2O2.
We use the information to maintain a list of approved firms and
processors for raw, bulk collagen, and gelatin. We make the list
available on our Web site. We include on the list only firms and
processors that are not the subject of an unresolved regulatory
enforcement action. If a listed firm or processor subsequently becomes
the subject of a regulatory enforcement action or an unresolved warning
letter, we will view such a circumstance as evidence that the firm or
processor is no longer in compliance with applicable U.S. laws and
regulations. Should this occur, we will take steps to remove that firm
or processor from the list and send a revised list to the EC
authorities, usually within 48 to 72 hours after the relevant
regulatory enforcement action. If a firm or processor has been delisted
as a result of a regulatory enforcement action or unresolved warning
letter, the firm or processor will have to reapply for inclusion on the
list once the regulatory action has been resolved.
We update the list of firms and processors eligible to export raw,
bulk collagen, and gelatin to the EC quarterly. Firms and processors
placed on the approved exporters list are subject to audit by FDA and
EC officials. Complete requests for inclusion must be submitted to us
every 12 months to remain on the list. Inclusion on the list is
voluntary. However, raw, bulk collagen, and gelatin products from firms
or processors not on the approved exporters list for these products
will not receive an export certificate, and these products may be
detained at EC ports of entry.
Description of Respondents: The respondents to this collection of
information include U.S. producers of shell eggs, dairy products, game
meat, game meat products, animal casings, gelatin, and collagen.
In the Federal Register of December 26, 2013 (78 FR 78364) FDA
published a 60-day notice requesting public comment on the proposed
collection of information. No comments were received.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of
Products Number of responses per Total annual Average burden Total hours
respondents respondent responses per response
----------------------------------------------------------------------------------------------------------------
Shell Eggs...................... 10 1 10 0.25 3
Dairy........................... 120 1 120 0.25 30
Game Meat and Game Meat Products 5 1 5 0.25 1
Animal Casings.................. 5 1 5 0.25 1
Gelatin......................... 3 1 3 0.25 1
Collagen........................ 3 1 3 0.25 1
-------------------------------------------------------------------------------
Total....................... .............. .............. .............. .............. 37
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
We base our estimates of the number of respondents and total annual
responses on the submissions that we have received in the past 3 years
for each product type. We have retained our previous estimates of total
annual responses because the number of submissions are few and have
remained relatively stable. To calculate the estimate for the hours per
response values, we assumed that the information requested is readily
available to the submitter. We expect that the submitter will need to
gather information from appropriate persons in the submitter's company
and to prepare this information for submission. We believe that this
effort should take no longer
[[Page 11448]]
than 15 minutes (0.25 hour) per response. We estimate that we will
receive 1 submission from 10 shell egg producers annually, for a total
of 10 annual responses. Each submission is estimated to take 0.25 hour
per response for a total of 2.5 hours, rounded to 3. We estimate that
we will receive 1 submission from 120 dairy product producers annually,
for a total of 120 annual responses. Each submission is estimated to
take 0.25 hour per response for a total of 30 hours. We estimate that
we will receive one submission from five game meat and game meat
product producers annually, for a total of five annual responses. Each
submission is estimated to take 0.25 hour per response for a total of
1.25 hours, rounded to 1 hour. We estimate that we will receive one
submission from five animal casings producers annually, for a total of
five annual responses. Each submission is estimated to take 0.25 hour
per response for a total of 1.25 hours, rounded to 1 hour. We estimate
that we will receive one submission from three gelatin producers
annually, for a total of three annual responses. Each submission is
estimated to take 0.25 hour per response for a total of 0.75 hour,
rounded to 1 hour. We estimate that we will receive one submission from
three collagen producers annually, for a total of three annual
responses. Each submission is estimated to take 0.25 hour per response
for a total of 0.75 hour, rounded to 1 hour. Therefore, the proposed
annual burden for this information collection is 37 hours.
Dated: February 24, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-04348 Filed 2-27-14; 8:45 am]
BILLING CODE 4160-01-P
